Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR(−/−) Mice

Astragaloside IV (AS-IV) is the main active compound of Astragalus membranaceus. In this study, we investigated whether AS-IV could attenuate atherosclerosis and hepatic steatosis in LDLR−/−mice and its potential mechanisms. After 12 weeks of high fat diet, the LDLR−/−mice were randomly divided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yifan, Du, Min, Wang, Jiarou, Liu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899310/
https://www.ncbi.nlm.nih.gov/pubmed/35264962
http://dx.doi.org/10.3389/fphar.2022.828161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899310/
https://www.ncbi.nlm.nih.gov/pubmed/35264962
http://dx.doi.org/10.3389/fphar.2022.828161

Ejemplares similares